GlassScriptPhysician profile
Katherine Fd Macarthur
NPI 1821391350
$341.49
in general payments reported to CMS, 2019-2025
9 companies · $134 in 2025
The $134 reported for 2025 was more than what 81% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $33.54 · 2023: $65.75 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $86.57 | 2021 | |
| Becton, Dickinson and Company | $71.52 | 2025 | Hemosphere |
| Merck Sharp & Dohme LLC | $52.84 | 2021-2023 | Bridion |
| Abiomed | $43.53 | 2025 | |
| Edwards Lifesciences Corporation | $28.89 | 2023 | |
| Heron Therapeutics, INC. | $19.09 | 2025 | Zynrelef |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.07 | 2022 | |
| Fisher & Paykel Healthcare INC | $15.14 | 2023 | Fisher & Paykel Healthcare |
| Ambu INC. | $4.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Macarthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.